Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Use of Dapsone Gel, 5% for Treating Dermatitis Herpetiformis

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified April 2010 by Vanderbilt University.
Recruitment status was:  Not yet recruiting
Sponsor:
Information provided by:
Vanderbilt University
ClinicalTrials.gov Identifier:
NCT01115244
First received: April 23, 2010
Last updated: April 29, 2010
Last verified: April 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: April 2011
  Estimated Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)